ONTOLOGY REPORT - ANNOTATIONS
| Term: | Hypertriglyceridemia |
|
| Accession: | RDO:0005845
|
browse the term
|
| Definition: | A condition of elevated levels of TRIGLYCERIDES in the blood. |
| Synonyms: | exact_synonym: | Hypertriglyceridemias |
| | primary_id: | MESH:D015228 |
| | alt_id: | OMIM:107741 |
|
|
Hypertriglyceridemia
|
| G |
Acp1 |
acid phosphatase 1, soluble |
|
|
ISS |
6 |
48,784,243 |
48,798,868 |
RGD:1625288 |
RGD |
| G |
Adrb2 |
adrenoceptor beta 2, surface |
|
|
IEA |
18 |
58,174,958 |
58,177,000 |
RGD:1331525 |
RGD |
| G |
Ahsg |
alpha-2-HS-glycoprotein |
|
|
ISS |
11 |
80,330,615 |
80,336,658 |
RGD:2313809 |
RGD |
| G |
Angptl3 |
angiopoietin-like 3 |
|
|
ISS |
5 |
119,479,669 |
119,484,358 |
RGD:1578347 |
RGD |
| G |
Apoa1 |
apolipoprotein A-I |
|
No_Association |
ISS |
|
|
|
RGD:1601187 |
RGD |
| G |
Apoa2 |
apolipoprotein A-II |
|
|
ISS |
13 |
87,114,734 |
87,116,372 |
RGD:1601190 |
RGD |
| G |
Apoa4 |
apolipoprotein A-IV |
|
|
ISS |
8 |
49,233,142 |
49,233,431 |
RGD:5685672 |
RGD |
| G |
Apoa5 |
apolipoprotein A-V |
|
|
IEP |
8 |
49,253,538 |
49,255,777 |
RGD:2313328 |
RGD |
| G |
Apoa5 |
apolipoprotein A-V |
|
|
ISS |
8 |
49,253,538 |
49,255,777 |
RGD:2313317 |
RGD |
| G |
Apoa5 |
apolipoprotein A-V |
|
|
ISS |
8 |
49,253,538 |
49,255,777 |
RGD:1578414 |
RGD |
| G |
Apoc1 |
apolipoprotein C-I |
|
|
ISS |
1 |
78,996,677 |
78,999,960 |
RGD:2313953 |
RGD |
| G |
Apoc2 |
apolipoprotein C-II |
|
|
ISS |
1 |
78,979,034 |
78,984,002 |
RGD:1601214 |
RGD |
| G |
Apoc2 |
apolipoprotein C-II |
|
Susceptibility |
ISS |
1 |
78,979,034 |
78,984,002 |
RGD:1601205 |
RGD |
| G |
Apoc3 |
apolipoprotein C-III |
|
|
ISS |
|
|
|
RGD:1578444 |
RGD |
| G |
Apoc3 |
apolipoprotein C-III |
|
Susceptibility |
ISS |
|
|
|
RGD:2306767 |
RGD |
| G |
Apoe |
apolipoprotein E |
|
Resistance |
ISS |
1 |
79,003,634 |
79,006,387 |
RGD:1601235 |
RGD |
| G |
Apoe |
apolipoprotein E |
|
|
ISS |
1 |
79,003,634 |
79,006,387 |
RGD:1601230 |
RGD |
| G |
Apoe |
apolipoprotein E |
|
|
ISS |
1 |
79,003,634 |
79,006,387 |
RGD:7240710 |
OMIM |
| G |
Bche |
butyrylcholinesterase |
|
|
ISS |
2 |
164,329,613 |
164,427,994 |
RGD:1601335 |
RGD |
| G |
F7 |
coagulation factor VII (serum prothrombin conversion accelerator) |
|
|
ISS |
16 |
81,348,678 |
81,358,991 |
RGD:2312379 |
RGD |
| G |
Fabp2 |
fatty acid binding protein 2, intestinal |
|
|
ISS |
2 |
219,591,502 |
219,605,097 |
RGD:1626401 |
RGD |
| G |
Gfpt1 |
glutamine fructose-6-phosphate transaminase 1 |
|
|
ISS |
4 |
121,204,274 |
121,250,160 |
RGD:1625423 |
RGD |
| G |
Hcrt |
hypocretin |
|
|
IAGP |
10 |
89,699,633 |
89,700,847 |
RGD:1358428 |
RGD |
| G |
Hnf4a |
hepatocyte nuclear factor 4, alpha |
|
|
ISS |
3 |
154,459,863 |
154,482,825 |
RGD:1601642 |
RGD |
| G |
Il6st |
interleukin 6 signal transducer |
|
|
IED |
2 |
43,806,301 |
43,842,365 |
RGD:1626687 |
RGD |
| G |
Insig1 |
insulin induced gene 1 |
|
Severity |
ISS |
4 |
2,577,468 |
2,585,682 |
RGD:2308857 |
RGD |
| G |
Insig2 |
insulin induced gene 2 |
|
Severity |
ISS |
13 |
33,331,951 |
33,345,132 |
RGD:2308857 |
RGD |
| G |
Lcat |
lecithin cholesterol acyltransferase |
|
|
ISS |
19 |
35,781,507 |
35,784,966 |
RGD:1581778 |
RGD |
| G |
Lipc |
lipase, hepatic |
|
|
ISS |
8 |
75,323,442 |
75,450,353 |
RGD:2308846 |
RGD |
| G |
Lipe |
lipase, hormone sensitive |
|
|
IED |
1 |
80,663,791 |
80,682,480 |
RGD:2313581 |
RGD |
| G |
Lipi |
lipase, member I |
|
Susceptibility |
ISS |
11 |
14,336,377 |
14,376,050 |
RGD:1625450 |
RGD |
| G |
Lpl |
lipoprotein lipase |
|
|
IED |
16 |
22,533,105 |
22,556,905 |
RGD:2313581 |
RGD |
| G |
Lpl |
lipoprotein lipase |
|
Susceptibility |
ISS |
16 |
22,533,105 |
22,556,905 |
RGD:2313305 |
RGD |
| G |
Lpl |
lipoprotein lipase |
|
|
ISS |
16 |
22,533,105 |
22,556,905 |
RGD:1580533 |
RGD |
| G |
Lta |
lymphotoxin alpha (TNF superfamily, member 1) |
|
Susceptibility |
ISS |
20 |
3,657,842 |
3,659,848 |
RGD:1625036 |
RGD |
| G |
Lta |
lymphotoxin alpha (TNF superfamily, member 1) |
|
No_Association |
ISS |
20 |
3,657,842 |
3,659,848 |
RGD:1625035 |
RGD |
| G |
Nos3 |
nitric oxide synthase 3, endothelial cell |
|
|
IEP |
4 |
6,158,847 |
6,179,441 |
RGD:2292131 |
RGD |
| G |
Pde5a |
phosphodiesterase 5A, cGMP-specific |
|
|
IPM |
2 |
219,410,394 |
219,550,910 |
RGD:2314464 |
RGD |
| G |
Plin2 |
perilipin 2 |
|
|
ISS |
5 |
105,718,496 |
105,732,817 |
RGD:1625752 |
RGD |
| G |
Serpinf2 |
serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 2 |
|
|
ISS |
10 |
62,748,116 |
62,756,200 |
RGD:1625533 |
RGD |
| G |
Socs1 |
suppressor of cytokine signaling 1 |
|
|
ISS |
10 |
4,819,971 |
4,820,609 |
RGD:1625677 |
RGD |
| G |
Socs3 |
suppressor of cytokine signaling 3 |
|
|
ISS |
10 |
107,958,468 |
107,959,330 |
RGD:1625677 |
RGD |
| G |
Trpm1 |
transient receptor potential cation channel, subfamily M, member 1 |
|
|
ISS |
1 |
118,583,516 |
118,700,653 |
RGD:7175561 |
RGD |
| G |
Txnip |
thioredoxin interacting protein |
|
Susceptibility |
ISS |
2 |
191,356,954 |
191,360,757 |
RGD:1642750 |
RGD |
| G |
Vldlr |
very low density lipoprotein receptor |
|
|
IEP |
1 |
230,666,736 |
230,697,748 |
RGD:1625577 |
RGD |
| Q |
Hrtrt8 |
Heart rate QTL 8 |
|
|
IED |
5 |
2,965,857 |
49,767,421 |
RGD:727992 |
RGD |
| Q |
Niddm57 |
Non-insulin dependent diabetes mellitus QTL 57 |
|
|
IED |
1 |
229,876,870 |
267,593,558 |
RGD:619679 |
RGD |
| Q |
Scl5 |
Serum cholesterol level QTL 5 |
|
|
IED |
1 |
243,502,887 |
267,910,886 |
RGD:619667 |
RGD |
| Q |
Stl1 |
Serum triglyceride level QTL 1 |
|
|
QTM |
|
|
|
RGD:619656 |
RGD |
| Q |
Stl10 |
Serum triglyceride level QTL 10 |
|
|
IAGP |
4 |
17,617,956 |
41,729,771 |
RGD:737686 |
RGD |
| Q |
Stl11 |
Serum triglyceride level QTL 11 |
|
|
IAGP |
7 |
126,748,283 |
143,002,779 |
RGD:737686 |
RGD |
| Q |
Stl12 |
Serum triglyceride level QTL 12 |
|
|
IAGP |
11 |
68,234,781 |
87,759,784 |
RGD:737686 |
RGD |
| Q |
Stl13 |
Serum triglyceride level QTL 13 |
|
|
IAGP |
17 |
27,118,351 |
71,570,057 |
RGD:1302893 |
RGD |
| Q |
Stl14 |
Serum triglyceride level QTL 14 |
|
|
IAGP |
7 |
119,494,698 |
141,116,327 |
RGD:1357168 |
RGD |
| Q |
Stl19 |
Serum triglyceride level QTL 19 |
|
|
IAGP |
4 |
460,493 |
64,750,077 |
RGD:1357415 |
RGD |
| Q |
Stl2 |
Serum triglyceride level QTL 2 |
|
|
IED |
4 |
461,376 |
54,828,069 |
RGD:619667 |
RGD |
| Q |
Stl29 |
Serum triglyceride level QTL 29 |
|
|
IAGP |
13 |
88,260,176 |
90,551,272 |
RGD:1299960 |
RGD |
| Q |
Stl30 |
Serum triglyceride level QTL 30 |
|
|
IAGP |
16 |
28,455,247 |
73,455,247 |
RGD:1299960 |
RGD |
| Q |
Stl31 |
Serum triglyceride level QTL 31 |
|
|
IED |
1 |
244,611,037 |
267,910,886 |
RGD:619669 |
RGD |
| Q |
Stl4 |
Serum triglyceride level QTL 4 |
|
|
IED |
4 |
72,160,227 |
134,858,710 |
RGD:631174 |
RGD |
| Q |
Stl5 |
Serum triglyceride level QTL 5 |
|
|
IED |
8 |
28,414,004 |
58,991,068 |
RGD:631174 |
RGD |
| Q |
Stl6 |
Serum triglyceride level QTL 6 |
|
|
IED |
8 |
64,616,911 |
116,844,692 |
RGD:631174 |
RGD |
| Q |
Stl7 |
Serum triglyceride level QTL 7 |
|
|
IED |
11 |
29,744,366 |
84,560,241 |
RGD:727992 |
RGD |
| Q |
Stl8 |
Serum triglyceride level QTL 8 |
|
|
IED |
1 |
230,963,695 |
267,910,886 |
RGD:70852 |
RGD |
| Q |
Stl9 |
Serum triglyceride level QTL 9 |
|
|
IED |
8 |
44,484,347 |
74,178,405 |
RGD:70852 |
RGD |
| S |
EHC/Seac |
|
|
|
IED |
|
|
|
RGD:2300117 |
RGD |
| S |
HTG |
Prague hypertriglyceridemic |
|
|
QTM |
|
|
|
RGD:1299960 |
RGD |
| S |
LH/Mav |
|
|
|
IED |
|
|
|
RGD:1580389 |
RGD |
| S |
PD/Cub |
polydactylous |
|
Model |
TAS |
|
|
|
RGD:1580750 |
RGD |
| S |
SDT.ZDF-Leprfa/Jtt |
SDT fatty |
|
|
IED |
|
|
|
RGD:2314022 |
RGD |
| S |
SHR-Tg(PEPCK-SREBF1)2Ipcv |
|
|
|
IED |
|
|
|
RGD:2313691 |
RGD |
| S |
SS-Tg(ApoC3-CETP)53Opaz |
|
|
|
IAGP |
|
|
|
RGD:2290427 |
RGD |
| S |
SS/JrHsdMcwi |
|
|
|
IED |
|
|
|
RGD:727992 |
RGD |
| S |
WOKW |
|
|
|
QTM |
|
|
|
RGD:1357168 |
RGD |
| S |
WOKW/K |
|
|
|
TAS |
|
|
|
RGD:619689 |
RGD |
Hyperlipoproteinemia Type IV
|
| S |
HTG |
Prague hypertriglyceridemic |
|
|
TAS |
|
|
|
RGD:1299960 |
RGD |
Hyperlipoproteinemia Type V
|
| G |
Apoa5 |
apolipoprotein A-V |
|
|
ISS |
8 |
49,253,538 |
49,255,777 |
RGD:7240710 |
OMIM |
Term paths to the root
|